Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-15,700
Closed -$298K 6354
2024
Q2
$298K Buy
+15,700
New +$294K ﹤0.01% 4914
2023
Q4
Sell
-100,000
Closed -$2.09M 6377
2023
Q3
$2.09M Buy
+100,000
New +$1.99M ﹤0.01% 3509
2014
Q4
Sell
-50,000
Closed -$3.81M 4173
2014
Q3
$3.81M Sell
50,000
-94,600
-65% -$7.82M 0.01% 1451
2014
Q2
$11.9M Buy
+144,600
New +$10.8M 0.03% 738

Other funds holding NOV

Israel Englander's NOV Position: Q2 2026 in Review

Israel Englander reduced its NOV (NOV) stake by 10% in Q2 2026, selling an estimated $5.92M and leaving 2,589,188 shares worth $48M. The position accounts for 0.02% of the portfolio, ranked #922.

Israel Englander first reported a position in NOV in Q3 2013 and has held it in 43 quarters since. The position peaked at $103M in Q1 2024. 485 funds tracked by Wall St. Rank hold NOV as of Q2 2026.

  • Israel Englander held 2,589,188 shares of NOV worth $48M as of Q2 2026.
  • Israel Englander sold 297,222 NOV shares in Q2 2026, an estimated $5.92M.
  • NOV made up 0.02% of Israel Englander's portfolio in Q2 2026, its #922 holding.
  • Israel Englander first reported a position in NOV in Q3 2013 and has held it in 43 quarters since.
  • Israel Englander's NOV position peaked at $103M in Q1 2024.
  • 485 funds tracked by Wall St. Rank held NOV as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.